
4D Molecular Therapeutics, Inc.
USD9.53
+0.26 (+2.80%)
CEO
David H. Kirn
IPO Date
2020-12-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.28
Prev. Close
$9.27
Day Low
$8.97
Day High
$9.65
52W Low
$3.68
52W High
$12.34
Market Cap
$0.50B
Volume
0.91M
| 18 Dec 2025 |
| Chardan Capital |
| Buy |
| Buy |
| maintain |
| 11 Nov 2025 | Barclays | Overweight | Overweight | maintain |
| 11 Nov 2025 | Chardan Capital | Buy | Buy | maintain |
| 11 Nov 2025 | RBC Capital | Outperform | Outperform | maintain |
| 21 Oct 2025 | RBC Capital | Outperform | Outperform | maintain |
| 12 Aug 2025 | Roth Capital | Buy | Buy | maintain |
| 12 Aug 2025 | Chardan Capital | Buy | Buy | maintain |